Onderneming Exalenz Bioscience Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
IL0011048688
Medische apparatuur, benodigdheden & distributie
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 01-10-10 |
Moshe Dori
DFI | Director of Finance/CFO | - | 29-01-19 |
Eitan Blank
COO | Chief Operating Officer | 54 | 01-01-07 |
Ofer Schlesinger
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-07-14 |
Ilan Ben Oren
CTO | Chief Tech/Sci/R&D Officer | 59 | 11-04-06 |
Didier Samuel
PRN | Corporate Officer/Principal | - | - |
Ari Soae
PRN | Corporate Officer/Principal | 46 | 01-01-06 |
Ilan Haikin
AUD | Comptroller/Controller/Auditor | 69 | 21-11-10 |
Gavin Doree
SAM | Sales & Marketing | 47 | 29-07-13 |
Susan Alpert
LAW | General Counsel | 78 | 01-01-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 04-07-16 |
Moshe Arkin
BRD | Director/Board Member | 69 | 01-01-06 |
Hanna Lerman
BRD | Director/Board Member | 51 | 16-04-15 |
Itai Arkin
BRD | Director/Board Member | 35 | 16-04-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 26 917 095 | 6 557 013 ( 24,36 %) | 0 | 24,36 % |
Bedrijfsgegevens
Meridian Bioscience Israel Ltd.
4 Ha'maayan Street
7177872, Modi'in-Maccabim-Re'ut
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,43% | 182 mld. | |
+4,30% | 114 mld. | |
-3,09% | 68,38 mld. | |
+5,86% | 52,46 mld. | |
+8,15% | 44,25 mld. | |
+7,52% | 43,55 mld. | |
+25,54% | 32,69 mld. | |
+17,85% | 26,73 mld. | |
+1,00% | 25,79 mld. |